Drug Delivery Devices Market Expected to Achieve 6.2% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Drug Delivery Devices Market Size By 2025?
Recent years have seen a robust growth in the market size of drug delivery devices. The market will expand from $91.03 billion in 2024 to $95.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.4%. This growth trajectory during the historic period is attributable to factors such as a surge in the elderly population, an enhancement in the count of healthcare facilities, economic ascent in emerging markets, and a boost in healthcare expenditure.

How Big Is the Drug Delivery Devices Market Size Expected to Grow by 2029?
Predictions indicate robust expansion in the drug delivery devices market in the years to come, with a projected increase to $122.16 billion by 2029 and a compound annual growth rate (CAGR) of 6.2%. A variety of factors are expected to contribute to this growth in the forecast period, including the rising prevalence of chronic illnesses, heightened demand for injectable drugs, an increased demand for drug delivery devices, and the sudden emergence of severe infectious diseases. Noteworthy trends for the forecast period include the investment in microneedle drug technology, research, and creation of self-injectable drug delivery devices, a focus on mergers and acquisitions, and investment in wearable drug delivery devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which Key Market Drivers Powering Drug Delivery Devices Market Expansion and Growth?
The escalating incidence of chronic illnesses such as cardiovascular problems, diabetes, cancer and other diseases is predicted to influence the drug delivery devices market positively. For example, the National Library of Medicine, a medical library run by the United States federal government, reported in January 2023 that the number of people over 50 in the country with at least one chronic illness is expected to surge by 99.5%. This means the number could go from 71.522 million in 2020 to about 142.66 million by 2050. There are a number of different methods for administering medical drugs. New drug delivery systems' creation is a significant aspect in the pharmaceutical field. Due to the rising incidence of these diseases globally, drug delivery research and development (R&D) is also on the rise. Numerous pharmaceutical firms are focusing on varied drug delivery technologies to enhance the benefits and results of their products in the market. Therefore, the escalating prevalence of chronic diseases is leading to a higher need for therapeutic drugs and treatments. This is expected to serve as a catalyst for the expansion of the drug delivery devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

Which Emerging Trends Are Transforming the Drug Delivery Devices Market in 2025?
Leading enterprises in the drug delivery device market are concentrating on the creation of revolutionary devices like autoinjectors, featuring full-built-in connectivity in order to maintain their market superiority. Autoinjectors, the medical devices intended for self-dosing with a preset medication amount, are becoming more common, as seen with Jabil Healthcare's unveiling of the Qfinity autoinjector platform in May 2022. This reusable drug delivery device, manufactured by the US-based healthcare manufacturing solutions firm, is a unique, reusable, and modular platform for subcutaneous self-administration of drugs. It provides an economically viable option against market rivals and encourages environmentally friendly drug delivery within the pharmaceutics sector. The versatile Qfinity design caters to a wide range of drug capacities and consistencies, with a cost per injection up to 65% lower than that of prevailing disposable autoinjectors due to a design centred around the patient. The sturdy Qfinity device is capable of more than 100 injections using 1 mL or 2.25 mL preloaded disposable cassettes while achieving a 65% reduction in injection costs via minimized component and material usage. Moreover, it results in a 60% drop in the carbon footprint, a 50% decrease in manufacturing space, and a 70% diminishment in CAPEX.

What Are the Emerging Segments in the Drug Delivery Devices Market?
The drug delivery devices market covered in this report is segmented -

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Who Are the Global Leaders in the Drug Delivery Devices Market?
Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Which are the Top Profitable Regional Markets for the Drug Delivery Devices Industry?
North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.